Medical News

RSS

Coenzyme Q10 to slow down the effects of Parkinson's disease?

Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the U.S. and Canada to determine whether a vitamin-like substance, in high doses, can slow the progression of Parkinson's disease, a neurodegenerative disorder that affects about one million people in the United States.

22 Sep 2009

Health of American workers trending downwards

In the midst of the most vigorous national health care debate in 15 years, and at a time of heightened economic insecurity, new data on employers show that the health of employed American workers is trending downward in a number of important areas. The State of Health in the American Workforce, a report released today by the Families and Work Institute (FWI), finds that only 28% of employees today report that their overall health is "excellent," down from 34% just six years ago.

22 Sep 2009

AHF’s first AIDS treatment center to open in Washington, DC

AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF’s first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria. The health care center, AHF’s first to be named in honor of Hollywood actor and longtime AIDS advocate Blair Underwood, will include a state-of-the-art, full-service HIV/AIDS treatment clinic as well as an on-site AHF Pharmacy. The facility will be known as the AHF Blair Underwood Clinic.

22 Sep 2009

Interim data from Micromet's T-cell engaging BiTE antibody study for treating solid tumors

Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors.

22 Sep 2009

Signaling molecules have different effects on key inhibitory protein

Researchers have identified a mechanism that may keep a well known signaling molecule from eroding bone and inflaming joints, according to an early study published online today in the Journal of Clinical Investigation.

22 Sep 2009

HTA acquires GHS medical office building portfolio

Healthcare Trust of America, Inc., (the "REIT"), a self-managed non-traded real estate investment trust, announced the completed acquisition of a 16-building portfolio from Greenville Hospital System ("GHS") based in Greenville, South Carolina for approximately $162,820,000 on September 18, 2009.

22 Sep 2009

Research reveals that thin people influence the way others around them eat

Thin friends who eat a lot could put your waistline at risk, according to a new study in the Journal of Consumer Research, which examines how other peoples' weight and food choices influence how much we eat.

22 Sep 2009

Bacterium responsible for outbreaks identified

University of Central Florida Microbiology Professor Keith Ireton has uncovered a previously unknown mechanism that plays an important role in the spread of a deadly food-borne bacterium.

22 Sep 2009

FDA announces grants to address unmet pediatric device needs

The U.S. Food and Drug Administration today announced the awarding of three grants to stimulate the development and availability of medical devices for children.

22 Sep 2009

New device could be the solution to menstrual pain

While most women experience minor pain during menstruation, for others, the pain can be severe enough to interfere with everyday activities and require medication. New research to be presented at the 2009 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition will reveal initial findings of safety surrounding a new device that may more effectively treat menstrual pain.

22 Sep 2009

Congress urged to delay pending Medicaid cuts

A diverse coalition of health care industry groups has sent an urgent letter to the bipartisan leadership in Congress seeking to delay pending Medicaid cuts and to enact a more equitable formula to reimburse pharmacies for dispensing generic drugs to Medicaid beneficiaries.

22 Sep 2009

Older adults with vitamin D deficiency at a greater risk of heart disease and death

A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.

22 Sep 2009

Dalton Pharma expands pharmaceutical manufacturing services

Dalton Pharma Services is pleased to announce the expansion of its pharmaceutical manufacturing services by adding Formulation Development to its list of integrated capabilities.

22 Sep 2009

CED urges Senate Finance Committee to adopt "Free Choice" amendment in health bill

The Committee for Economic Development (CED) today urged the Senate Finance Committee to amend the America's Health Future Act (sponsored by Senate Finance Committee Chairman Max Baucus (D-MT)) by adopting the "Free Choice" amendment submitted Senator Ron Wyden (D-OR). The "Free Choice" amendment is a key element of the Healthy Americans Act (S. 391) which was endorsed by CED in June of this year.

22 Sep 2009

Duke University awarded $19.5M to design a portable viral infection detection device

The Defense Advanced Research Projects Agency (DARPA), the research arm of the U.S. Department of Defense, has awarded Duke University $19.5 million for an effort led by the Duke Institute for Genome Sciences & Policy (IGSP) to design a portable, easy-to-use diagnostic device that can reveal who is infected with an upper respiratory virus before the first cough or sneeze.

22 Sep 2009

Novel cleavage sites for enzyme caspase-3 identified

Investigators at Burnham Institute for Medical Research (Burnham) have identified novel cleavage sites for the enzyme caspase-3 (an enzyme that proteolytically cleaves target proteins). Using an advanced proteomic technique called N-terminomics, Guy Salvesen, Ph.D., professor and director of the Apoptosis and Cell Death Research program of Burnham's NCI-designated Cancer Center, and colleagues determined the cleavage sites on target proteins and found, contrary to previous understanding, that caspase-3 targets α-helices as well as unstructured loops.

22 Sep 2009

Boehringer Ingelheim to acquire certain assets of Wyeth Pharmaceutical after Pfizer-Wyeth merger

Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical's Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger, which is expected to occur early in the fourth quarter.

22 Sep 2009

NASDAQ issues noncompliance letter to Bionovo

Bionovo, Inc. (Nasdaq: BNVI) today announced that on September 15, 2009, the company received a letter from NASDAQ stating that, for the last 30 consecutive business days, the bid price of its common stock has closed below the minimum $1.00 per share requirement for continued listing on the NASDAQ Capital Market.

22 Sep 2009

Collaborative initiative to address nursing shortage

The Robert Wood Johnson Foundation (RWJF) and the Northwest Health Foundation (NWHF) today issued its Call for Proposal for Partners Investing in Nursing's Future (PIN), a collaborative initiative that addresses the nursing shortage at the community level through funding partnerships with local and regional foundations.

22 Sep 2009

ALDA Pharmaceuticals raises funds through private placement

ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) (the "Company") is pleased to announce that it has closed the private placement originally announced in a news release dated July 17, 2009.

22 Sep 2009